Home » Topics » Conferences

Conferences
RSS

Atypical antipsychotic developed at Esteve characterized

Nov. 11, 1997

New C5a antagonist reduces cardiac ischemia-reperfusion injury in micropig model

Nov. 11, 1997

MK-966 assessed in large trial in osteoarthritis of the knee and hip

Nov. 11, 1997

Fibrinogen receptor occupancy, antiplatelet activity and safety of lefradafiban

Nov. 10, 1997

Mechanism of action of triptolide investigated in human T-cells

Nov. 10, 1997

SB-234551 prevents radiocontrast-induced renal vasoconstriction in dogs

Nov. 10, 1997

RenaGel with and without calcium effective in ESRD

Nov. 10, 1997

Efficacy of NC-100100 demonstrated in dogs

Nov. 10, 1997

Lamifiban efficacy demonstrated in PARAGON trial

Nov. 10, 1997

Preclinical and clinical profile of Searle's fibrinogen antagonist

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...